EndovasMedical celebrated the official launch of its V-SAILING® peripheral venous thrombectomy stent system at VINNOVA 2026 (the 11th Vascular Innovation Conference) in Beijing, where the product was also recognized as one of the Top 10 Innovative Medical Devices of 2025. The launch event featured keynote addresses by leading vascular surgery experts and in-depth academic discussions on the device's clinical advantages.
Clinical trial data across 146 patients demonstrated an overall thrombus clearance rate of 86.25%, validating the product's efficacy across acute, subacute and chronic DVT stages. EndovasMedical continues to advance domestic innovation in vascular intervention devices, working with clinical experts to bring safer, more effective solutions to patients.